BioAmber Inc., an industrial biotechnology company producing sustainable chemicals, has signed a take-or-pay contract for bio-based 1,4-Butanediol (BDO) with Vinmar International. Under the terms of the 15-year master off-take agreement, ...
German automaker Audi has entered into a strategic partnership with French biotechnology company Global Bioenergies to promote the development of non-fossil fuels. Under this collaboration, Audi will research into e-gasoline apart from ...
Tags: Green Fuels, Audi
Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines (LAIVs) against seasonal and pandemic influenza, today announced that it has signed a Cooperative Research and Development ...
Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma ...
Z Trim Holdings, Inc., a biotechnology company providing value-added ingredients to a variety of industries, today announced that it recorded, for the 4th quarter of 2013, $387,006 in sales which is a 76% increase over $220,433 in the 4th ...
Tags: dairy, salad dressings, sauces
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with ...
Tags: Immunocore, oncology research, collaboration and licensing agreement
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network ...
Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study
Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders ...
Tags: Ikaria, sell the Commercial Business, Madison Dearborn Partners
China's rejection of US corn that contains an unapproved genetically modified strain is unlikely to cause major price fluctuations in the domestic or US markets, analysts said. Quarantine authorities in four provinces have rejected 12 ...
Tags: US corn, genetically modified strain, price fluctuations
US-based biotechnology company United Therapeutics has obtained an approval from the US Food and Drug Administration (FDA) for the Orenitram (treprostinil) extended-release tablets, indicted for the treatment of pulmonary arterial ...
Tags: Extended-Release Tablets, Medicine
Z Trim Holdings, Inc., a biotechnology company providing value-added ingredients to companies in the food and industrial markets, announced that it has entered into an agreement with a leading multi-national specialty food products company. ...
Tags: Multi-National Specialty Food Products, Agriculture, Food
BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...